Key result
Epigenetic regulation of ion channels is linked to cardiac fibrosis, providing potential therapeutic and biomarker targets.
Its licence doesn't allow us to show a copy here.
Why the study?
There was little systematic overview of the epigenetic regulation of ion channels contributing to cardiac fibrosis.
This review highlights the role of epigenetic regulation of ion channels in cardiac fibrosis, offering insights into potential therapeutic interventions and biomarkers.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for epigenetic therapies in cardiac fibrosis; prospective trials needed before clinical adoption.
Cardiac fibrosis is a pathological process characterized by excessive collagen deposition and abnormal proliferation of cardiac fibroblasts. This condition can lead to impaired cardiac function and ventricular remodeling. The development of cardiac fibrosis involves multiple mechanisms, and studies confirm that epigenetic mechanisms play a crucial part in cardiac fibrosis. Maintaining ion channel homeostasis is essential for optimal cardiac function; any imbalance can induce a range of cardiovascular diseases. However, there is little in the way of a systematic overview of the epigenetic regulation of ion channels contributing to cardiac fibrosis. This review systematically summarizes the epigenetic mechanisms underlying ion channel-mediated cardiac fibrosis and discusses potential interventions and biomarkers, along with the challenges in this rapidly evolving field.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2026) conducted a review in Cardiac fibrosis. Epigenetic regulation of ion channels plays a crucial role in the development of cardiac fibrosis, providing potential targets for future interventions and biomarkers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: